* biOasis Technologies Inc – Says under terms of agreement,
Vaccinex will have right to commercialize its anti-Semaphorin 4D
antibody technology
The post BRIEF-biOasis enters into a license agreement with Vaccinex Inc. appeared first on NASDAQ.
Forex – financial instrument.Forex news
* biOasis Technologies Inc – Says under terms of agreement,
Vaccinex will have right to commercialize its anti-Semaphorin 4D
antibody technology
The post BRIEF-biOasis enters into a license agreement with Vaccinex Inc. appeared first on NASDAQ.